Viyash Scientific Limited (VIYASH) — Financial Results

📢 Key Event
Viyash Scientific reported FY26 revenue of ₹34,203 crores, up 13.8% YoY, with EBITDA at ₹7,025 crores, up 59.6% YoY, and net debt reduced to ₹4,511 crores.

🔄 What Changed
Net debt reduced to ₹4,511 crores; EBITDA margin expanded to 21.7% from prior periods; merger synergies beginning to reflect in financials.

🔮 What's Next
Actively evaluating selective inorganic opportunities to further strengthen platform and create long-term value; excited about product pipeline and growth roadmap for FY27.

💡 Investor Takeaway
The company is deleveraging and showing strong margin expansion, signaling improved profitability and operational efficiency for shareholders.

Viyash Scientific reported FY26 revenue of ₹34,203 crores, up 13.8% YoY, with EBITDA at ₹7,025 crores, up 59.6% YoY, and net debt reduced to ₹4,511 crores. The company highlighted strong Q4 performance, merger synergies, and a deleveraged balance sheet as it advances into FY27 with a robust pipeline and inorganic growth plans.

📄 View Original Announcement (PDF)

📊 Stock Analysis — VIYASH ✨ Ask AI About This